Overview


According to FutureWise analysis the market for percutaneous transluminal coronary angioplasty (ptca) balloon catheters in 2023 is US$ 1.31 billion, and is expected to reach US$ 1.89 billion by 2031 at a CAGR of 4.60%.

The market for percutaneous transluminal coronary angioplasty (PTCA) balloon catheters is driven by its ease of use, safety, and cost-effectiveness. When interventional devices are delivered to the peripheral or coronary vascular systems, guiding catheters are used to indicate this. The primary advantage of PTCA is that it eliminates the post-operative discomforts associated with coronary bypass surgery while lowering morbidity. The global PTCA balloon catheter market is being propelled by an increase in the geriatric population and an increase in the prevalence of cardiovascular disease. Because the risk of cardiovascular problems increases with age, the geriatric population is expected to drive the growth of the PTCA balloon catheters market.
Percutaneous Transluminal Coronary Angioplasty (PTCA) is a minimally invasive treatment used to unblock blocked or restricted coronary arteries caused by coronary artery disease (CAD). Without the need for open-heart surgery, PTCA balloon catheters allow blood to flow freely from the arteries to the heart muscles.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Alvi Medica
  • Abott Laboratories
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Ivascular
  • Ronstis
  • Koninklijke Phillips
  • Medtronic Plc
  • Balton Sp Zoo
  • B.braun Melsungen Ag

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Normal balloon catheter
  • Drug eluting balloon catheter
  • Cutting balloon catheter
  • Scoring balloon catheter

By Delivery Platform

  • Rapid Exchange (RX) / Monorail balloon catheter
  • Over-the-wire (OTW) balloon catheter

By Compliance

  • Semi-Compliant
  • Non-Compliant

By Balloon Material

  • Polyolefin copolymer (POC)
  • Polyethylene (PE)
  • Polyethylene terephthalate (PET)

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market By Product, By Delivery Platform, By Compliance, By Balloon Material and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Normal balloon catheter
        2. Drug eluting balloon catheter
        3. Cutting balloon catheter
        4. Scoring balloon catheter

  • 8.   Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market, By Delivery Platform Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Rapid Exchange (RX) / Monorail balloon catheter
        2. Over-the-wire (OTW) balloon catheter

  • 9.   Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market, By Compliance Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Semi-Compliant
        2. Non-Compliant

  • 10.   Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market, By Balloon Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Polyolefin copolymer (POC)
        2. Polyethylene (PE)
        3. Polyethylene terephthalate (PET)

  • 11.   North America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Alvi Medica
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abott Laboratories
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific Corporation
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Becton, Dickinson and Company
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Ivascular
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Ronstis
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Koninklijke Phillips
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Medtronic Plc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Balton Sp Zoo
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. B.braun Melsungen Ag
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients